The association of leptin with dyslipidemia, arterial hypertension and obesity in Kyrgyz (Central Asian nation) population

BMC Research Notes

Volumn 7, Issue 1, 2014, Pages

  Irrakhimov, Erkin M ^a,b,c   Kerimkulova, Alina S ^a   Lunegova, Olga S ^b   Mirrakhimov, Aibek E ^a   Nabiev, Malik P ^a   Neronova, Kseniya V ^a   Bayramukova, Asiyat A ^a   Alibaeva, Nazira T ^c   Satarov, Nurdin ^a  

^a Kyrgyz State Medical Academy   (Kyrgyzstan)

^b Internal Medicine named after M Mirrakhimov   (Kyrgyzstan)

^c KYRGYZ RUSSIAN SLAVIC UNIVERSITY   (Kyrgyzstan)

Author keywords

Abdominal obesity; Arterial hypertension; Dyslipidemia; Leptin

Indexed keywords

GLUCOSE BLOOD LEVEL; INSULIN; LEPTIN; TRIACYLGLYCEROL;

ADIPOSE TISSUE; ADULT; BLOOD; BLOOD PRESSURE; BODY COMPOSITION; BODY MASS; COMPLICATION; DIABETES MELLITUS, TYPE 2; DYSLIPIDEMIAS; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; INSULIN RESISTANCE; KYRGYZSTAN; MALE; METABOLISM; MIDDLE AGED; OBESITY; PATHOPHYSIOLOGY; RISK FACTOR; STATISTICAL MODEL; WAIST CIRCUMFERENCE;

ADIPOSE TISSUE; ADULT; BLOOD GLUCOSE; BLOOD PRESSURE; BODY COMPOSITION; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; DYSLIPIDEMIAS; FEMALE; HUMANS; HYPERTENSION; INSULIN; INSULIN RESISTANCE; KYRGYZSTAN; LEPTIN; LOGISTIC MODELS; MALE; MIDDLE AGED; OBESITY; RISK FACTORS; TRIGLYCERIDES; WAIST CIRCUMFERENCE;

EID: 84903327165     PISSN: None     EISSN: 17560500     Source Type: Journal    
DOI: 10.1186/1756-0500-7-411     Document Type: Article

References (58)

1. Global Status Report on non-communicable diseases 2010. WHO, Alwan A, 2011 164 Available on http://whqlibdoc.who.int/publications/2011/9789240686458- eng.pdf?ua=1
2. Epidemiology of cardiovascular disease in the 21st century: updated numbers and updated facts. Santulli G, JCvD 2013 1 1 2
3. Coronary heart disease risk factors and mortality. Santulli G, JAMA 2012 307 11 1137
4. AHA/ACC/TOS guideline for the management of overweight and obesity in adults. Jensen MD, Ryan DH, Apovian CM, Loria CM, Ard JD, Millen BE, Comuzzie AG, Nonas CA, Donato KA, Pi-Sunyer FX, Hu FB, Stevens J, Hubbard VS, Stevens VJ, Jakicic JM, Wadden TA, Kushner RF, Wolfe BM, Yanovski SZ, JACC 2013 2013 doi:10.1016/j.jacc.2013.11.004
5. The epidemiology of central fat distribution in relation to disease. Pi-Sunyer FX, Nutr Rev 2004 62 120 S126
6. Endocrine regulation of energy metabolism: review of pathobiochemical and clinical aspects of leptin, ghrelin, adiponectin, and resistin. Meier U, Gressner AM, Clin Chem 2004 50 1511 1525
7. Positional cloning of the mouse obese gene and its human homologue. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM, Nature 1994 372 425 432
8. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, Ohannesian JP, Marco CC, McKee LJ, Bauer TL, Caro JF, N Engl J Med 1996 334 292 295
9. Role of leptin in obesity-related hypertension. Haynes WG, Exp Physiol 2005 90 683 688
10. Association between serum leptin concentrations and insulin resistance: a population-based study from China. Zuo H, Shi Z, Yuan B, Dai Y, Wu G, Hussain A, PLoS One 2013 8 1 54615 doi:10.1371/journal.pone.0054615
11. Associations of visceral adiposity and exercise participation with C-reactive protein, insulin resistance, and endothelial dysfunction in Korean healthy adults. Kim K, Valentine RJ, Shin Y, Gong K, Metabolism 2008 57 9 1181 9 doi:10.1016/j.metabol.2008.04.009
12. Comprehensive analysis of circulating adipokines and hsCRP association with cardiovascular disease risk factors and metabolic syndrome in Arabs. Abu-Farha M, Behbehani K, Elkum N, Cardiovasc Diabetol 2014 13 1 76 doi:10.1186/1475-2840-13-76
13. Comparison of obesity and its relationship to some metabolic risk factors of atherosclerosis in Arabs and south Asians in Kuwait. Babusik P, Duris I, Med Princ Pract 2010 19 275 280
14. Healthcare needs assessment. Black and minority ethnic groups. Gill PS, Kai J, Bhopal RS, Wild S, http://hcna.radcliffe-oxford.com/bemgframe.htm
15. Role of diabetes in congestive heart failure: the Framingham study. Kannel WB, Hjortland M, Castelli WP, Am J Cardiol 1974 34 29 34
16. Insulin resistance and congestive heart failure. Stefan N, Fritsche A, Haring HU, JAMA 2005 294 334 341
17. Obesity and the risk of heart failure. Kenchaiah S, Evans JC, Levy D, Wilson PW, Benjamin EJ, Larson MG, Kannel WB, Vasan RS, N Engl J Med 2002 347 305 313
18. National Center for Health Statistics, Health United States 2003 with chart book on trends in the health of Americans Hyattsville, MD: U.S. Department of Health and Human services Centers for Disease Control and Prevention National Center for Health Statistics 2003 26 31 http://www.cdc.gov/nchs/data/ hus/hus03.pdf
19. Diagnosis and management of the metabolic syndrome: an American heart association/national heart, lung and blood institute scientific statement. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC Jr, Spertus JA, Costa F, Curr Opin Cardiol 2006 21 1 6
20. The diabetes risk score: a practical tool to predict type 2 diabetes risk. Lindstrom J, Tuomilehto J, Diabetes Care 2003 26 725 731
21. An association between Trp64Arg polymorphism of the b3 adrenoreceptor gene and some metabolic disturbances. Mirrakhimov AE, Kerimkulova AS, Lunegova OS, Moldokeeva CB, Zalesskaya YV, Abilova SS, Sovhozova NA, Aldashev AA, Mirrakhimov EM, Cardiovasc Diabetol 2011 10 89
22. Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Friedewald WT, Levy RI, Fredrickson DS, Clin Chem 1972 18 499 502
23. Leptin concentrations in relation to overall adiposity, fat distribution, and blood pressure in a rural Chinese population. Hu FB, Chen C, Wang B, Stampfer MJ, Xu X, Int J Obes Relat Metab Disord 2001 25 121 125
24. Leptin concentration in women is influenced by regional distributi on of adipose tissue. Bennett FI, McFarlane-Anderson N, Wilks R, Luke A, Cooper RS, Forrester TE, Am J Clin Nutr 1997 66 1340 1344
25. Gender differences in plasma leptin concentrations. Havel PJ, Kasim-Karakas S, Dubuc OR, Mueller W, Phinney SD, Nat Med 1996 2 949 950
26. Effects of gender, body composition, and menopause on plasma concentrations of leptin. Rosenbaum M, Nicolson M, Hirsch J, Heymsfield SB, Gallagher D, Chu F, Leibel RL, J Clin Endocrinol Metab 1996 81 3424 3427
27. High plasma leptin concentrations in hypertensive men but not in hypertensive women. Sheu WH, Lee WJ, Chen YT, J Hypertens 1999 17 1289 1295
28. Impact of obesity on metabolism in men and women. Importance of regional adipose tissue distribution. Krotkiewski M, Bjorntorp P, Sjostrom L, Smith U, J Clin Invest 1983 72 1150 1162
29. Leptin plasma concentrations are dependent on body fat distribution in obese patients. Minocci A, Savia G, Lucantoni R, Berselli ME, Tagliaferri M, Calo G, Petroni ML, de Medici C, Viberti GC, Liuzzi A, Int J Obes 2000 24 1139 1144
30. Sexual dimorphism of age-related changes in whole-body fat distribution in the obese. Kotani K, Tokunaga K, Fujioka S, Kobatake T, Keno Y, Yoshida S, Shimomura I, Tarui S, Matsuzawa Y, Int J Obes Relat Metab Disord 1994 18 207 210
31. Circulating ghrelin, leptin, and soluble leptin receptor concentrations and cardiometabolic risk factors in a community-based sample. Ingelsson E, Larson MG, Yin X, Wang TJ, Meigs JB, Lipinska I, Benjamin EJ, Keaney JF Jr, Vasan RS, J Clin Endocrinol Metab 2008 93 3149 3157
32. The metabolic significance of leptin in humans: gender-based differences in relationship to adiposity, insulin sensitivity, and energy expenditure. Kennedy A, Gettys TW, Watson P, Wallace P, Ganaway E, Pan Q, Garvey WT, J Clin Endocrinol Metab 1997 82 1293 1300
33. Testosterone substitution normalizes elevated serum leptin levels in hypogonadal men. Jockenhovel F, Blum WF, Vogel E, Englaro P, Müller-Wieland D, Reinw ein D, Rascher W, Krone W, Reinwein D, Rascher W, Krone W, J Clin Endocrinol Metab 1997 82 2510 2513
34. Serum leptin levels in patients with hyperlipidemias. Haluzik M, Fiedler J, Nedvidkova J, Ceska R, Nutrition 2000 16 429 433
35. Elevated leptin concentrations in growth hormone-deficient hypopituitary adults. Al-Shoumer KA, Anyaoku V, Richmond W, Johnston DG, Clin Endocrinol 2000 47 153 159
36. Serum leptin levels are independently correlated with two measures of HDL. Rainwater DL, Comuzzie AG, VandeBerg JL, Mahaney MC, Blangero J, Atherosclerosis 1997 32 237 243
37. Circulating leptin concentrations in polycystic ovary syndrome: relation to anthropometric and metabolic parameters. Chapman IM, Wittert GA, Norman RJ, Clin Endocrinol 1997 46 175 181
38. Hyperleptinemia as a component of a metabolic syndrome of cardiovascular risk. Leyva F, Godsland IF, Ghatei M, Proudler AJ, Aldis S, Walton C, Bloom S, Stevenson JC, Arterioscler Thromb Vasc Biol 1998 18 928 933
39. Pathophysiology of childhood obesity. Rosenbaum M, Leibel RL, Adv Pediatr 1988 35 73 137
40. The role of leptin in human physiology. Rosenbaum M, Leibel RL, N Engl J Med 1999 341 879 884
41. Total body lipid and triglyceride response to energy deficit: relevance to body composition models. Comizio R, Pietrobelli A, Tan YX, Wang Z, Withers RT, Heymsfield SB, Boozer CN, Am J Physiol 1998 274 860 866
42. Plasma leptin and blood pressure in men: graded association independent of body mass and fat pattern. Barba G, Russo O, Siani A, Iacone R, Farinaro E, Gerardi MC, Russo P, Della Valle E, Strazzullo P, Obes Res 2003 11 160 166
43. Chronic leptin infusion increases arterial pressure. Shek EW, Brands MW, Hall JE, Hypertension 1998 31 409 414
44. Pathophysiological role of leptin in obesity-related hypertension. Aizawa-Abe M, Ogawa Y, Masuzaki H, Ebihara K, Satoh N, Iwai H, Matsuoka N, Hayashi T, Hosoda K, Inoue G, Yoshimasa Y, Nakao K, J Clin Invest 2000 105 1243 1252
45. Plasma leptin concentration, insulin sensitivity, and 24-hour ambulatory blood pressure and left ventricular geometry. Paolisso G, Tagliamonte MR, Galderisi M, Zito GA, D'Errico A, Marfella R, Carella C, de Divitiis O, Varricchio M, Am J Hypertens 2001 14 114 120
46. Pressure mediated hypertrophy and mechanical stretch up-regulate expression of the long form of leptin receptor (ob-Rb) in rat cardiac myocytes. Matsui H, Yokoyama T, Tanaka C, Sunaga H, Koitabashi N, Takizawa T, Arai M, Kurabayashi M, BMC Cell Biol 2012 27 13 37
47. Dissociation between muscle and skin sympathetic activity in essential hypertension, obesity, and congestive heart failure. Grassi G, Colombo M, Sevalle G, Spaziani D, Manci G, Hypertension 1998 31 64 67
48. Regional sympathetic nervous activity and oxygen consumption in obese normotensive human subjects. Vaz M, Jennings G, Turner A, Cox H, Lambert G, Esler M, Circulation 1997 96 3423 3429
49. Leptin and the central neural mechanisms of obesity hypertension. Rahmouni K, GHaynes W, Drugs Today (Barc) 2002 38 12 807 17
50. The neurobiology of human obesity. Eikelis N, Esler M, Exp Physiol 2005 90 673 682
51. Prevalence of insulin resistance in metabolic disorders: the Bruneck Study. Bonora E, Kiechl S, Willeit J, Oberhollenzer F, Egger G, Targher G, Alberiche M, Bonadonna RC, Muggeo M, Diabetes 1998 47 1643 1649
52. Hypertension and associated metabolic abnormalities-the role of insulin resistance and the sympathoadrenal system. Reaven GM, Lithell H, Landsberg L, The New Engl J of Med 1996 334 6 374 381
53. Association of leptin receptor gene polymorphisms and essential hypertension in a Chinese population. Gu P, Jiang W, Chen M, Lu B, Shao J, Du H, Jiang S, J Endocrinol Investig 2012 35 9 859 865
54. Evaluation of leptin and leptin receptor gene 30 UTR polymorphisms in essential hypertension. Nagalingam S, Uppuluri MV, Gunda P, Ravishanker U, Tirunilai P, Clin Exp Hypertens Early Online: 1-7, doi:10.3109/10641963.2013. 846356
55. 3 subunit and its association with obesity in the Kyrgyz population. Mirrakhimov EM, Lunegova OS, Mirrakhimov AE, Kerimkulova AS, Starov N, Abilova SS, Zalesskaya YV, Alibaeva NT, Aldashev AA, Family medicine and community health 2013 1 1 23 29
56. CaMK4 gene deletion induces hypertension. Santulli G, Cipolletta E, Sorriento D, Del Giudice C, Anastasio A, Monaco S, Maione AS, Condorelli G, Puca A, Trimarco T, Illario M, Iaccarino G, J Am Heart Assoc 2012 1 4 001081
57. The G protein coupled receptor kinase 2 plays an essential role in beta-adrenergic receptor-induced insulin resistance. Cipolletta E, Campanile A, Santulli G, Sanzari E, Leosco D, Campiglia P, Trimarco B, Iaccarino G, Cardiovasc Res 2009 84 3 407 415
58. Plasma leptin and the risk of cardiovascular disease in the west of Scotland coronary prevention study (WOSCOPS). Wallace AM, McMahon AD, Packard CJ, Kelly A, Shepherd J, Gaw A, Sattar N, Circulation 2001 104 3052 3056